Get the Stockscreener App
24.81
3.96%
0.9704
Schrodinger Inc stock is traded at $24.81, with a volume of 599.01K.
It is up +3.96% in the last 24 hours and up +5.20% over the past month.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
See More
Previous Close:
$23.84
Open:
$24.21
24h Volume:
599.01K
Relative Volume:
0.52
Market Cap:
$1.59B
Revenue:
$193.35M
Net Income/Loss:
$-177.58M
P/E Ratio:
-10.13
EPS:
-2.45
Net Cash Flow:
$-172.43M
1W Performance:
+14.64%
1M Performance:
+5.20%
6M Performance:
+13.48%
1Y Performance:
+5.92%
1-Day Range:
$23.98
$24.92
1-Week Range:
$21.23
$24.92
52-Week Range:
$16.60
$28.47
Schrodinger Inc Stock (SDGR) Company Profile
Name
Schrodinger Inc
Sector
Industry
Phone
503-299-1150
Address
1540 BROADWAY, NEW YORK, NY
Compare SDGR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
24.84 | 1.57B | 193.35M | -177.58M | -172.43M | -2.45 |
|
VEEV
Veeva Systems Inc
|
288.75 | 45.60B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
62.31 | 9.42B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
112.26 | 8.73B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
58.62 | 9.76B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
40.89 | 6.67B | 906.14M | -52.62M | 89.62M | -0.3621 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-02-24 | Initiated | Leerink Partners | Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-05-23 | Resumed | Piper Sandler | Overweight |
| Dec-19-22 | Initiated | Goldman | Neutral |
| Mar-01-22 | Initiated | Citigroup | Buy |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Nov-11-21 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-13-21 | Initiated | Berenberg | Buy |
| Sep-01-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-25-21 | Initiated | Craig Hallum | Buy |
| Nov-23-20 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-12-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-02-20 | Initiated | BMO Capital Markets | Outperform |
| Mar-02-20 | Initiated | Jefferies | Hold |
| Mar-02-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Schrodinger Inc Stock (SDGR) Latest News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, ... - Bluefield Daily Telegraph
Bronstein, Gewirtz & Grossman, LLC Is Investigating Schrödinger, Inc. (SDGR) And Encourages Shareholders to Connect - ACCESS Newswire
24,500 Shares in Schrödinger, Inc. (NASDAQ:SDGR) Acquired by Two Sigma Advisers LP - Defense World
Bank of America Corp DE Reduces Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Schrodinger at Jefferies Conference: Strategic Growth and Challenges By Investing.com - Investing.com Nigeria
Schrodinger at Jefferies Conference: Strategic Growth and Challenges - Investing.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Schrödinger, Inc. (SDGR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Schrödinger, Inc. (SDGR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc.SDGR - FinancialContent
Two Sigma Investments LP Acquires New Stake in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Schrödinger, Inc. (SDGR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Top 5 AI & Digital Biotech Companies (June 2025) - Securities.io
Schrödinger, Inc. (SDGR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
ProShare Advisors LLC Has $323,000 Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Layoff Tracker: iTeos Winds Down Operations - BioSpace
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule - GuruFocus
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer - 01net
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer | SDGR Stock News - GuruFocus
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) To Newly Appointed Chief Commercial Officer - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Schrödinger, Inc. (SDGR) And Encourages Investors to Connect - ACCESS Newswire
Schrodinger appoints Mannix Aklian as chief commercial officer - TipRanks
Schrödinger Appoints Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing - citybiz
Schrödinger Expands Executive Leadership Team with Appointment o - GuruFocus
Schrödinger Expands Executive Leadership Team With Appointment Of Mannix Aklian As Chief Commercial Officer - marketscreener.com
Schrödinger Expands Executive Leadership Team with Appointment of Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing | SDGR Stock News - GuruFocus
Schrödinger Expands Executive Leadership Team with Appointment of Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing - Yahoo Finance
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $610,000 Stock Holdings in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Ameriprise Financial Inc. Has $2.67 Million Position in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
RXRX vs. SDGR: Which AI-Powered Drug Discovery Stock Has More Upside? - Zacks Investment Research
BNP Paribas Financial Markets Makes New Investment in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Schrödinger, Inc. (SDGR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
When the Price of (SDGR) Talks, People Listen - news.stocktradersdaily.com
Leadership Transition at Schrödinger: Richie Jain Named CFO - MSN
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | SDGR Stock News - GuruFocus
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geoffrey Porges exits Schrödinger with CFO swap; A new board seat for AstraZeneca's Pascal Soriot - Endpoints News
Schrödinger to Present at Jefferies Global Healthcare Conference - GuruFocus
Schrödinger to Present at Jefferies Global Healthcare Conference | SDGR Stock News - GuruFocus
Captrust Financial Advisors Takes $240,000 Position in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Schrodinger Inc (SDGR) Shares Gap Down to $21.34 on May 20 - GuruFocus
Schrodinger appoints new CFO, Richie Jain By Investing.com - Investing.com Nigeria
Schrödinger: Regulatory Tailwinds Are Supportive Of Continued Strong Growth (Rating Upgrade) - Seeking Alpha
Schrödinger appoints new CFO as Porges steps down By Investing.com - Investing.com South Africa
Schrödinger appoints new CFO as Porges steps down - Investing.com Australia
SDGR Makes Notable Cross Below Critical Moving Average - Nasdaq
Tourmaline shares fall on Phase 2 data; Schrödinger cuts staff - BioPharma Dive
SV Health’s $269M dementia fund; Schrödinger lays off 7% of staff - Endpoints News
Schrödinger (SDGR) Announces CFO Transition and Reaffirms 2025 O - GuruFocus
Schrödinger Announces Chief Financial Officer Changes - marketscreener.com
Schrodinger names Richie Jain as new CFO - Investing.com
Schrodinger names Richie Jain as new CFO By Investing.com - Investing.com South Africa
Schrodinger Inc Stock (SDGR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Schrodinger Inc Stock (SDGR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Akinsanya Karen | President of R&D, Therapeutics |
Apr 14 '25 |
Sale |
25.09 |
16,723 |
419,570 |
15,625 |
1.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):